Statistics

Total Visits

Views
Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study44

Select a period of time:

Number of views in the range

Views
Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study24

Views

Views
November 20241
December 20240
January 20252
February 20251
March 202517
April 20253
May 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore17
United States3
United Kingdom2
Brazil1
Spain1
 

Top cities views

Views
Council Bluffs1
Pasadena1
Xique Xique1